Karl-Heinz Krause Selected Research

Schizophrenia (Dementia Praecox)

7/2012	Targeting NOX enzymes in the central nervous system: therapeutic opportunities.
8/2010	The NADPH oxidase NOX2 controls glutamate release: a novel mechanism involved in psychosis-like ketamine responses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karl-Heinz Krause Research Topics

Disease

11	Neoplasms (Cancer) 03/2023 - 03/2006
10	Chronic Granulomatous Disease 01/2018 - 07/2008
9	Dementia (Dementias) 07/2023 - 11/2002
9	Inflammation (Inflammations) 01/2023 - 04/2005
9	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 10/2002
8	Infections 01/2023 - 02/2010
7	Alzheimer Disease (Alzheimer's Disease) 07/2012 - 10/2002
4	Wounds and Injuries (Trauma) 03/2023 - 01/2016
4	Hearing Loss (Hearing Impairment) 01/2022 - 10/2004
4	Parkinson Disease (Parkinson's Disease) 01/2021 - 11/2009
3	Neuroinflammatory Diseases 01/2023 - 01/2009
3	COVID-19 01/2023 - 01/2022
2	Ischemia 07/2023 - 10/2009
2	Disease Progression 07/2022 - 10/2017
2	Sensorineural Hearing Loss 01/2022 - 01/2022
2	Ototoxicity 01/2022 - 01/2021
2	Pain (Aches) 01/2021 - 12/2007
2	Glioblastoma (Glioblastoma Multiforme) 12/2017 - 09/2014
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2016 - 07/2012
2	Pathologic Processes 06/2014 - 01/2007
2	Stroke (Strokes) 06/2014 - 07/2012
2	Psychotic Disorders (Schizoaffective Disorder) 06/2014 - 08/2010
2	Hyperoxia 01/2014 - 11/2009
2	Atherosclerosis 09/2013 - 02/2010
2	Schizophrenia (Dementia Praecox) 07/2012 - 08/2010
2	Chronic Disease (Chronic Diseases) 03/2012 - 09/2010
2	Mixed Dementias 02/2011 - 12/2010
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 02/2011 - 12/2010
2	Neuroblastoma 11/2006 - 12/2003
1	Chronic Pain 01/2023
1	Osteoarthritis 01/2023
1	Hypersensitivity (Allergy) 10/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 07/2022
1	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 07/2022
1	Noise-Induced Hearing Loss (Acoustic Trauma) 01/2022
1	Idiopathic Pulmonary Fibrosis 11/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2021
1	Blister (Bulla) 01/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Congenital Hypothyroidism (Cretinism) 01/2019
1	Cardiomyopathies (Cardiomyopathy) 01/2019
1	Infarction (Infarctions) 01/2019
1	Heart Failure 01/2019
1	Primary Immunodeficiency Diseases 01/2019

Drug/Important Bio-Agent (IBA)

20	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2022 - 06/2003
18	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 10/2004
9	EnzymesIBA 01/2022 - 01/2007
6	Protein Isoforms (Isoforms)IBA 11/2017 - 11/2004
4	NADP (NADPH)IBA 12/2014 - 07/2007
4	Caspase 3 (Caspase-3)IBA 01/2014 - 12/2003
3	ChemokinesIBA 07/2023 - 12/2003
3	NADPH Oxidase 4IBA 01/2023 - 01/2016
3	AntibodiesIBA 07/2022 - 12/2007
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 11/2006
3	Superoxides (Superoxide)IBA 02/2010 - 07/2007
2	Apolipoproteins E (ApoE)IBA 07/2023 - 12/2010
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2021
2	CytokinesIBA 01/2019 - 09/2014
2	Nucleic AcidsIBA 11/2017 - 08/2009
2	AntioxidantsIBA 10/2017 - 01/2015
2	Oxidoreductases (Dehydrogenase)IBA 12/2014 - 07/2007
2	VaccinesIBA 08/2014 - 12/2007
2	Chemokine ReceptorsIBA 02/2011 - 02/2005
2	Small Interfering RNA (siRNA)IBA 04/2010 - 02/2010
2	Amyloid (Amyloid Fibrils)IBA 11/2006 - 10/2002
1	ApolipoproteinsIBA 07/2023
1	GelatinIBA 03/2023
1	Clofazimine (Lamprene)FDA Link 01/2023
1	CateninsIBA 01/2023
1	Protons (Proton)IBA 01/2023
1	CatalaseIBA 10/2022
1	CarbonIBA 10/2022
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 10/2022
1	Oxygen (Dioxygen)IBA 10/2022
1	ADAM17 ProteinIBA 07/2022
1	Acyclovir (Aciclovir)FDA LinkGeneric 01/2022
1	NucleosidesIBA 01/2022
1	Tyrosine (L-Tyrosine)FDA Link 11/2021
1	saccharide-binding proteinsIBA 10/2021
1	Galectin 3 (LGALS3)IBA 10/2021
1	Phenazopyridine (Pyridium)FDA LinkGeneric 01/2021
1	Cyclin GIBA 01/2021
1	SolutionsIBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2021
1	PlatinumIBA 01/2021
1	Dual OxidasesIBA 01/2019
1	Epoxide HydrolasesIBA 01/2019
1	IntegrinsIBA 12/2017

Therapy/Procedure

8	Therapeutics 01/2023 - 10/2009
6	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2023 - 09/2009
3	Transplantation 01/2016 - 09/2009
3	Institutionalization (Institutionalized Persons) 03/2012 - 03/2009
2	Length of Stay 09/2010 - 03/2009
2	Home Nursing (Nursing, Home) 03/2009 - 02/2004
1	Surgical Amputation (Amputations) 01/2023
1	Precision Medicine 01/2023
1	Oral Hygiene (Dental Hygiene) 10/2022
1	Drug Therapy (Chemotherapy) 01/2022
1	Ligation 01/2019